Friday, October 23, 2026
11:30 AM – 12:00 PM PT – Registration & Lunch
12:00 PM – 1:30 PM PT – CE Symposium
Caesars Palace
3570 S Las Vegas Blvd
Las Vegas, Nevada 89109
Meeting Room: Milano 1-3
PROGRAM FEATURES
- Interactive, case-based learning environment
- Create your own personalized poster
PRESENTING FACULTY
![]() |
Anna Chodos, MD, MPH Professor of Medicine Division of General Internal Medicine Zuckerberg San Francisco General Division of Geriatrics Department of Medicine University of California, San Francisco San Francisco, California |
![]() |
Rhonna Shatz, DO Bob and Sandy Heimann Chair in Alzheimer’s Disease Research and Education Director, Memory Care and Brain Health Center Professor of Neurology Department of Neurology and Rehabilitation University of Cincinnati Cincinnati, Ohio |
PROGRAM OVERVIEW
This symposium at OMED 2026 is designed to provide osteopathic clinicians with practical, evidence-based guidance on promoting brain health and advancing early detection of Alzheimer’s disease. The program will highlight the importance of brain health across the lifespan and of differentiating normal aging from mild cognitive impairment and early Alzheimer’s disease. It will also address integrating cognitive assessment with emerging blood-based biomarkers and identifying modifiable risk factors to support dementia risk reduction. Through expert presentations and interactive case-based discussions, participants will gain practical skills to interpret cognitive and biomarker findings, communicate results effectively with patients and care partners, and support earlier, patient-centered diagnosis and management of Alzheimer’s disease.
TARGET AUDIENCE
This educational initiative is designed to meet the needs of healthcare professionals involved in the assessment, diagnosis, and ongoing management of patients across the AD continuum, including primary care clinicians, neurologists, geriatricians, geriatric psychiatrists, nurse practitioners, and physician assistants.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Apply evidence-based cognitive health assessment strategies to differentiate normal aging, MCI, and early AD across the disease continuum
- Integrate blood-based biomarker testing into the diagnostic evaluation of suspected AD using guideline-informed test selection and result interpretation
- Implement patient-centered communication strategies to discuss cognitive health, diagnostic testing, and risk modification with patients and care partners
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in this live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of up to 1.5 ANCC contact hours.
AAPA CREDIT DESIGNATION STATEMENT – LIVE
Med Learning Group has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credits for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
ACCME INNOVATION PARTNER

Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event Staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to the live event at [email protected]


